G
Glenmark
Apri29, 2016
‘The Dy. General Manager
Dept. of corporate Afars
The Bombay Stock Exchange Ltd,
Phiroze leeleebhoy Towers
Dalal street
‘Mumba: 400008,
\We are enclosing herewith a press release informing “lenmark Pharmaceutials receives
tentative ANDA approval for Adapalene and Benzoy Peroxide Gel, 0.1% 2.5%" for your
Information an record
Thanking you
Yours fitful,
For Glenmark Pharmaceuticals id
‘sanjay Kumar Chowdhary
‘Company Secretary & Compliance Officer
Tet 4018 9999 / 4018 9879
Fx No: 4018 9886 (Legal & Secretarial Dept)
Encl: as aboveGS
glenmai
Forimmodiae Release
Glenmark Pharmaceuticals receives tentative ANDA approvel for,
‘Adapalene and Benzoyl Peroxide Gel, 0.1%|2.5%
ia; April 28,2016: Glenmark Pharmaceuticals Inc, USA (Glenmark) has been granted
‘entatve approval by the Unltd States Food & Orug Adminisation (US. FDA) for Adapalene and
Benzo! Peroxide Gel, 0.1%12.5% the gnerc version of Epidue® Galo Galderma Laboratories LP.
‘According to MS Heath sles data forthe 12 month petod ending February 2016, te Epido® Gel
market" achieved annual sales of approximately $351.8 milion*
‘Glenmark’ current portfolio consists of 112 protucts authored for strbution in the US.
‘marketlace and 58 ANDH's pending approval wih the U.S. FO. In addon to these interal ings,
‘Glenmark continues to identfy and explore external development partnerships to applement and
accelerate the growth ofits existing pipeline and portfolio.
"at ices and and alse hcp cals
Sh hea Natrol Persea Ret & Nao Ret eb 2036
2kSG
Glenmark
‘About lenmark Pharmaceuticals kd.
Glenmark Pharmaceuticals Lid. (GPL) Ie a reearcheven, global, Integrated pharmaceutical
organization headquartered at Mumbai, India. is ranked among the top BD Phirms & Biotech
companies ofthe world in texms of revenue (SCHP 100 Renkings published inthe year 2026),
“Glenmark sa leading player inthe discovery of new molecules bath NCES new chemical entity] and
INBES (now biological entity), Glenmark has several molecules in various stages of clinical
“development and is primary focused in the areas of inflammation [asthma/COPO, rheumatoid
artnet} and Pain neuropathic pln an iaiammatory pala
‘he company has siglcant presence in the branded generis markets across emeiing economies
Inclaing nd. GPL along with its subsidiary has 16 manufacturing acts across fe counties and
has sc RAD centers, The Generics business of Glenmark services the requirement of the US and
Western European markets. The APL business sels prosucts in aver 80 counties, including the US,
various countriesin the EU, South America and ni
For further information, lease contact:
Rarskumar Uppara/Shibani Shah
Glenmart, Mumba, nd
+91 22) 2026 s984/S34
mall: compconmddlenmarksharma com